Skip to content
10-Q

Quarterly Report

REMEDENT, INC.

0001144204-19-040094

← back to feed
Filed
Aug 14, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Aug 14, 2019 20M sh
Cash And Equivalents Q1 2020 · Jun 30, 2019 $79.54K
Cash And Equivalents Q1 2020 · Mar 31, 2019 $66.54K
Stockholders Equity Q1 2020 · Jun 30, 2019 $5.16M
Stockholders Equity Q1 2020 · Mar 31, 2019 $5.39M
Current Liabilities Q1 2020 · Jun 30, 2019 $2.59M
Current Liabilities Q1 2020 · Mar 31, 2019 $2.43M
Total Liabilities Q1 2020 · Jun 30, 2019 $2.68M
Total Liabilities Q1 2020 · Mar 31, 2019 $2.43M
Current Assets Q1 2020 · Jun 30, 2019 $854.03K
Current Assets Q1 2020 · Mar 31, 2019 $655.93K
Total Assets Q1 2020 · Jun 30, 2019 $7.93M
Total Assets Q1 2020 · Mar 31, 2019 $7.9M
Shares Diluted Q1 2020 · Jun 30, 2018 20M sh
Operating Cash Flow Q1 2020 · Jun 30, 2018 −$51.28K
Eps Diluted Q1 2020 · Jun 30, 2018 $0.00
Eps Basic Q1 2020 · Jun 30, 2018 $0.00
Sga Expense Q1 2020 · Jun 30, 2018 $267.47K
Rd Expense Q1 2020 · Jun 30, 2018 $120
Net Income Q1 2020 · Jun 30, 2018 −$158.76K
Operating Income Q1 2020 · Jun 30, 2018 −$156.59K
Gross Profit Q1 2020 · Jun 30, 2018 $329.31K
Cost Of Revenue Q1 2020 · Jun 30, 2018 $105.53K
Revenue Q1 2020 · Jun 30, 2018 $434.85K